A comprehensive investigation that measured phosphorylation occupancy at multiple tau residues in CSF showed that tau phosphorylation is dynamic and begins once the aggregated Aβ pathology is seen, changes over two decades of tracking the clinical progression of the disease, and goes down significantly in a site-dependent manner near the onset of cognitive decline [29]. This evidence concerns the gene MAPT and Mental deterioration.